An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer

This publication has 61 references indexed in Scilit:

• Systematic identification of genomic markers of drug sensitivity in cancer cells
  Nature, 2012
• The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
  Nature, 2012
• Hallmarks of Cancer: The Next Generation
  Cell, 2011
• COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
  Nature, 2010
• RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
  Nature, 2010
• Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
  Nature, 2009
• A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
  Cancer Cell, 2009
• Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
  Proceedings of the National Academy of Sciences, 2005
• Protein kinase CK2 phosphorylates and upregulates Akt/PKB
  Cell Death & Differentiation, 2005
• Dissemination and growth of cancer cells in metastatic sites
  Nature Reviews Cancer, 2002